Initial high-efficacy disease-modifying therapy in multiple sclerosisMathias Due Buron, Melinda Magyari, Thor Ameri Chalmer et al.|Neurology|2020Cited by 160
Early versus later treatment start in multiple sclerosis: a register‐based cohort studyThor Ameri Chalmer, Lisbeth M. Baggesen, Mette Nørgaard et al.|European Journal of Neurology|2018Cited by 109
Comparative effectiveness of teriflunomide and dimethyl fumarateMathias Due Buron, Melinda Magyari, Thor Ameri Chalmer et al.|Neurology|2019Cited by 45
Treatment escalation leads to fewer relapses compared with switching to another moderately effective therapyMelinda Magyari, Thor Ameri Chalmer, Tomáš Kalinčík et al.|Journal of Neurology|2018Cited by 29
Predictors of treatment outcome in patients with paediatric onset multiple sclerosisTine Iskov Kopp, Melinda Magyari, Morten Blinkenberg et al.|Multiple Sclerosis Journal|2019Cited by 22